Malkin M - Search Results

1

Booth L, Malkin M, Dent P. Booth L, et al. Among authors: malkin m. Aging (Albany NY). 2016 Jul;8(7):1289-90. doi: 10.18632/aging.101001. Aging (Albany NY). 2016. PMID: 27429364 Free PMC article. No abstract available.

2

PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells.

Roberts JL, Booth L, Conley A, Cruickshanks N, Malkin M, Kukreja RC, Grant S, Poklepovic A, Dent P. Roberts JL, et al. Among authors: malkin m. Cancer Biol Ther. 2014 Jun 1;15(6):758-67. doi: 10.4161/cbt.28553. Epub 2014 Mar 20. Cancer Biol Ther. 2014. PMID: 24651037 Free PMC article.

3

Phase I trial of dimethyl fumarate, temozolomide, and radiation therapy in glioblastoma.

Shafer D, Tombes MB, Shrader E, Ryan A, Bandyopadhyay D, Dent P, Malkin M. Shafer D, et al. Among authors: malkin m. Neurooncol Adv. 2020 Jan 24;2(1):vdz052. doi: 10.1093/noajnl/vdz052. eCollection 2020 Jan-Dec. Neurooncol Adv. 2020. PMID: 32642720 Free PMC article.

4

Treatment of Primary Central Nervous System Posttransplant Lymphoproliferative Disorder in an Adult Kidney Transplant Recipient: A Case Report.

Abbassi M, Riley R, Malkin M, Tang Y, Rajendran B, Yazbeck V. Abbassi M, et al. Among authors: malkin m. Exp Clin Transplant. 2019 Feb;17(1):111-114. doi: 10.6002/ect.2016.0171. Epub 2017 Apr 27. Exp Clin Transplant. 2019. PMID: 28447926 Free article. Review.

5

Journal Club: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma.

Alnahhas I, Malkin M. Alnahhas I, et al. Among authors: malkin m. Neurology. 2015 Dec 15;85(24):e187-9. doi: 10.1212/WNL.0000000000002213. Neurology. 2015. PMID: 26668244 Clinical Trial. No abstract available.

6

tRNA Function and Dysregulation in Cancer.

Gupta T, Malkin MG, Huang S. Gupta T, et al. Front Cell Dev Biol. 2022 Jun 1;10:886642. doi: 10.3389/fcell.2022.886642. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35721477 Free PMC article. Review.

7

Vinorelbine combined with a protracted course of temozolomide for recurrent brain metastases: a phase I trial.

Omuro AM, Raizer JJ, Demopoulos A, Malkin MG, Abrey LE. Omuro AM, et al. Among authors: malkin mg. J Neurooncol. 2006 Jul;78(3):277-80. doi: 10.1007/s11060-005-9095-8. Epub 2006 Apr 14. J Neurooncol. 2006. PMID: 16614943 Clinical Trial.

8

A phase II study of extended low-dose temozolomide in recurrent malignant gliomas.

Khan RB, Raizer JJ, Malkin MG, Bazylewicz KA, Abrey LE. Khan RB, et al. Neuro Oncol. 2002 Jan;4(1):39-43. doi: 10.1093/neuonc/4.1.39. Neuro Oncol. 2002. PMID: 11772431 Free PMC article. Clinical Trial.

9

Phase 1 study of 28-day, low-dose temozolomide and BCNU in the treatment of malignant gliomas after radiation therapy.

Raizer JJ, Malkin MG, Kleber M, Abrey LE. Raizer JJ, et al. Among authors: malkin mg. Neuro Oncol. 2004 Jul;6(3):247-52. doi: 10.1215/S1152851704000122. Neuro Oncol. 2004. PMID: 15279717 Free PMC article. Clinical Trial.

10

A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.

Abrey LE, Olson JD, Raizer JJ, Mack M, Rodavitch A, Boutros DY, Malkin MG. Abrey LE, et al. Among authors: malkin mg. J Neurooncol. 2001 Jul;53(3):259-65. doi: 10.1023/a:1012226718323. J Neurooncol. 2001. PMID: 11718258 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters